Wealthfront Advisers’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$288K Sell
9,331
-1,939
-17% -$59.6K ﹤0.01% 993
2026
Q2
$321K Sell
11,270
-5,748
-34% -$124K ﹤0.01% 969
2026
Q1
$195K Sell
17,018
-14,090
-45% -$198K ﹤0.01% 1028
2025
Q4
$447K Buy
31,108
+9,157
+42% +$158K ﹤0.01% 841
2025
Q3
$416K Sell
21,951
-21,890
-50% -$361K ﹤0.01% 844
2025
Q2
$940K Buy
+43,841
New +$652K ﹤0.01% 688

Other funds holding OSCR

Wealthfront Advisers's OSCR Position: Q3 2026 in Review

Wealthfront Advisers reduced its Oscar Health (OSCR) stake by 17% in Q3 2026, selling an estimated $59.6K and leaving 9,331 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #993.

Wealthfront Advisers first reported a position in OSCR in Q2 2025 and has held it in 6 quarters since. The position peaked at $940K in Q2 2025. 423 funds tracked by Wall St. Rank hold OSCR as of Q3 2026.

  • Wealthfront Advisers held 9,331 shares of Oscar Health worth $288K as of Q3 2026.
  • Wealthfront Advisers sold 1,939 Oscar Health shares in Q3 2026, an estimated $59.6K.
  • Oscar Health made up ﹤0.01% of Wealthfront Advisers's portfolio in Q3 2026, its #993 holding.
  • Wealthfront Advisers first reported a position in Oscar Health in Q2 2025 and has held it in 6 quarters since.
  • Wealthfront Advisers's Oscar Health position peaked at $940K in Q2 2025.
  • 423 funds tracked by Wall St. Rank held Oscar Health as of Q3 2026.

Based on Wealthfront Advisers's 13F filing for Q3 2026, filed 9 Nov 2026.